MORGUARD REIT (MRT-DB-A.CA) Stock Fundamental Analysis

TSX:MRT-DB-A • CA617914AP17

101.54 CAD
-0.21 (-0.21%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MRT-DB-A. MRT-DB-A was compared to 36 industry peers in the Diversified REITs industry. MRT-DB-A has a bad profitability rating. Also its financial health evaluation is rather negative. MRT-DB-A has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year MRT-DB-A has reported negative net income.
  • In the past year MRT-DB-A had a positive cash flow from operations.
  • MRT-DB-A had negative earnings in 4 of the past 5 years.
  • In the past 5 years MRT-DB-A always reported a positive cash flow from operatings.
MRT-DB-A.CA Yearly Net Income VS EBIT VS OCF VS FCFMRT-DB-A.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.03%, MRT-DB-A is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • MRT-DB-A has a Return On Equity of -5.06%. This is comparable to the rest of the industry: MRT-DB-A outperforms 41.67% of its industry peers.
  • The Return On Invested Capital of MRT-DB-A (4.23%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for MRT-DB-A is in line with the industry average of 5.59%.
Industry RankSector Rank
ROA -2.03%
ROE -5.06%
ROIC 4.23%
ROA(3y)-3.2%
ROA(5y)-4.67%
ROE(3y)-7.53%
ROE(5y)-10.61%
ROIC(3y)4.53%
ROIC(5y)4.4%
MRT-DB-A.CA Yearly ROA, ROE, ROICMRT-DB-A.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • Looking at the Operating Margin, with a value of 46.06%, MRT-DB-A is doing worse than 61.11% of the companies in the same industry.
  • MRT-DB-A's Operating Margin has declined in the last couple of years.
  • MRT-DB-A has a worse Gross Margin (47.63%) than 80.56% of its industry peers.
  • In the last couple of years the Gross Margin of MRT-DB-A has declined.
Industry RankSector Rank
OM 46.06%
PM (TTM) N/A
GM 47.63%
OM growth 3Y-1.47%
OM growth 5Y-1.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.99%
GM growth 5Y-2.03%
MRT-DB-A.CA Yearly Profit, Operating, Gross MarginsMRT-DB-A.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MRT-DB-A is destroying value.
  • The number of shares outstanding for MRT-DB-A has been reduced compared to 1 year ago.
  • MRT-DB-A has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MRT-DB-A has a worse debt to assets ratio.
MRT-DB-A.CA Yearly Shares OutstandingMRT-DB-A.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MRT-DB-A.CA Yearly Total Debt VS Total AssetsMRT-DB-A.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 3.32 indicates that MRT-DB-A is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.32, MRT-DB-A belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
  • MRT-DB-A has a debt to FCF ratio of 27.11. This is a negative value and a sign of low solvency as MRT-DB-A would need 27.11 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 27.11, MRT-DB-A is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • MRT-DB-A has a Debt/Equity ratio of 1.18. This is a high value indicating a heavy dependency on external financing.
  • MRT-DB-A has a Debt to Equity ratio of 1.18. This is comparable to the rest of the industry: MRT-DB-A outperforms 47.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 27.11
Altman-Z 3.32
ROIC/WACC0.58
WACC7.35%
MRT-DB-A.CA Yearly LT Debt VS Equity VS FCFMRT-DB-A.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • MRT-DB-A has a Current Ratio of 0.07. This is a bad value and indicates that MRT-DB-A is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MRT-DB-A's Current ratio of 0.07 is on the low side compared to the rest of the industry. MRT-DB-A is outperformed by 80.56% of its industry peers.
  • MRT-DB-A has a Quick Ratio of 0.07. This is a bad value and indicates that MRT-DB-A is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MRT-DB-A has a Quick ratio of 0.07. This is amonst the worse of the industry: MRT-DB-A underperforms 80.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
MRT-DB-A.CA Yearly Current Assets VS Current LiabilitesMRT-DB-A.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.75% over the past year.
  • The Revenue has decreased by -5.37% in the past year.
  • Measured over the past years, MRT-DB-A shows a decrease in Revenue. The Revenue has been decreasing by -1.04% on average per year.
EPS 1Y (TTM)21.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.99%
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y2.39%
Revenue growth 5Y-1.04%
Sales Q2Q%-8.86%

3.2 Future

  • The Earnings Per Share is expected to grow by 118.98% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -1.11% on average over the next years.
EPS Next Y170%
EPS Next 2Y211.45%
EPS Next 3Y118.98%
EPS Next 5YN/A
Revenue Next Year-11.35%
Revenue Next 2Y-3.98%
Revenue Next 3Y-1.11%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MRT-DB-A.CA Yearly Revenue VS EstimatesMRT-DB-A.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
MRT-DB-A.CA Yearly EPS VS EstimatesMRT-DB-A.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2023 2024 2025 2026 2027 0 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • MRT-DB-A reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • MRT-DB-A is valuated quite expensively with a Price/Forward Earnings ratio of 130.56.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MRT-DB-A is on the same level as its industry peers.
  • MRT-DB-A's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE N/A
Fwd PE 130.56
MRT-DB-A.CA Price Earnings VS Forward Price EarningsMRT-DB-A.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as MRT-DB-A.
  • Based on the Price/Free Cash Flow ratio, MRT-DB-A is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 147.33
EV/EBITDA 69.95
MRT-DB-A.CA Per share dataMRT-DB-A.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MRT-DB-A's earnings are expected to grow with 118.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y211.45%
EPS Next 3Y118.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.49%, MRT-DB-A is a good candidate for dividend investing.
  • With a Dividend Yield of 4.49, MRT-DB-A pays less dividend than the industry average, which is at 7.01. 80.56% of the companies listed in the same industry pay a better dividend than MRT-DB-A!
  • MRT-DB-A's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 4.49%

5.2 History

  • The dividend of MRT-DB-A decreases each year by -24.29%.
  • MRT-DB-A does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-24.29%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • The earnings of MRT-DB-A are negative and hence is the payout ratio. MRT-DB-A will probably not be able to sustain this dividend level.
DP-18.03%
EPS Next 2Y211.45%
EPS Next 3Y118.98%
MRT-DB-A.CA Yearly Income VS Free CF VS DividendMRT-DB-A.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

More info and screens

Find the best dividend stocksShow peers with best dividend

MORGUARD REIT

TSX:MRT-DB-A (2/20/2026, 7:00:00 PM)

101.54

-0.21 (-0.21%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-11
Earnings (Next)04-28
Inst Owners0.88%
Inst Owner ChangeN/A
Ins Owners16.2%
Ins Owner ChangeN/A
Market Cap6.75B
Revenue(TTM)243.77M
Net Income(TTM)-44.09M
Analysts50
Price Target93.27 (-8.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.49%
Yearly Dividend0.24
Dividend Growth(5Y)-24.29%
DP-18.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.06%
PT rev (3m)-2.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-41.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 130.56
P/S 27.67
P/FCF 147.33
P/OCF 147.33
P/B 7.74
P/tB 7.74
EV/EBITDA 69.95
EPS(TTM)-0.69
EYN/A
EPS(NY)0.78
Fwd EY0.77%
FCF(TTM)0.69
FCFY0.68%
OCF(TTM)0.69
OCFY0.68%
SpS3.67
BVpS13.12
TBVpS13.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.03%
ROE -5.06%
ROCE 6.32%
ROIC 4.23%
ROICexc 4.25%
ROICexgc 4.25%
OM 46.06%
PM (TTM) N/A
GM 47.63%
FCFM 18.78%
ROA(3y)-3.2%
ROA(5y)-4.67%
ROE(3y)-7.53%
ROE(5y)-10.61%
ROIC(3y)4.53%
ROIC(5y)4.4%
ROICexc(3y)4.55%
ROICexc(5y)4.42%
ROICexgc(3y)4.55%
ROICexgc(5y)4.42%
ROCE(3y)6.57%
ROCE(5y)6.31%
ROICexgc growth 3Y6.46%
ROICexgc growth 5Y4.22%
ROICexc growth 3Y6.46%
ROICexc growth 5Y4.22%
OM growth 3Y-1.47%
OM growth 5Y-1.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.99%
GM growth 5Y-2.03%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 27.11
Debt/EBITDA 9.16
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.85
Cash Conversion 40.75%
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 3.32
F-Score4
WACC7.35%
ROIC/WACC0.58
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.99%
EPS Next Y170%
EPS Next 2Y211.45%
EPS Next 3Y118.98%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y2.39%
Revenue growth 5Y-1.04%
Sales Q2Q%-8.86%
Revenue Next Year-11.35%
Revenue Next 2Y-3.98%
Revenue Next 3Y-1.11%
Revenue Next 5YN/A
EBIT growth 1Y-9.88%
EBIT growth 3Y0.89%
EBIT growth 5Y-2.94%
EBIT Next Year-10.49%
EBIT Next 3Y-0.2%
EBIT Next 5YN/A
FCF growth 1Y-31.07%
FCF growth 3Y-12.1%
FCF growth 5Y-9.44%
OCF growth 1Y-31.07%
OCF growth 3Y-12.1%
OCF growth 5Y-9.44%

MORGUARD REIT / MRT-DB-A.CA FAQ

What is the fundamental rating for MRT-DB-A stock?

ChartMill assigns a fundamental rating of 2 / 10 to MRT-DB-A.CA.


What is the valuation status for MRT-DB-A stock?

ChartMill assigns a valuation rating of 2 / 10 to MORGUARD REIT (MRT-DB-A.CA). This can be considered as Overvalued.


Can you provide the profitability details for MORGUARD REIT?

MORGUARD REIT (MRT-DB-A.CA) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for MRT-DB-A stock?

The Earnings per Share (EPS) of MORGUARD REIT (MRT-DB-A.CA) is expected to grow by 170% in the next year.